比亞迪 (1211.HK) 銷量一路飆升

12 Jul 2022

投資概要
銷量一路飆升,六月同比+163%
最新的銷售數據顯示,比亞迪六月份新能源汽車銷量再創歷史新高:共銷售新能源汽
車 134036 台,同比+163%,環比+17%,預計將高於國內新能源車的整體漲幅。前六個
月累計銷量為 641350 台,按年升 314.9%,完成其年度銷量目標 150 萬台的 43%。
分類別看,新能源商用車六月的銷量為 274 輛,同比/環比分別-78%/-64%。純電乘用
車銷售 69544 台,同比+247%,環比+30%;插電混乘用車 64218 台,同比+219.5%,環
比+5.6%,前六個月累計分別為 323519,314638 台,按年+246%,+454%。前者主要由
深圳工廠擴產帶動,後者環比增幅略低則因受長沙工廠停工調查影響。
多款車型持續熱銷,新車密集發佈
六月隨著復工復產持續推進,整體車市回暖。憑藉極強的產品競爭力,王朝系列中的
旗艦車型“漢”持續熱銷,已連續幾個月錄得大幅上漲,六月更是連續兩個月突破 2 萬
+,銷量達到 25439 台,同比+203%,其中漢 DMI 交付同比+386%,漢 EV 交付接近 1.3
萬台。首六個月的累計銷售超 25 萬輛,繼續領跑同級別轎車細分市場。
王 朝 系 列 的 其 他 車 型 銷 量 亦 十 分 強 勁 : 唐 / 秦 / 宋 / 元 系 列 的 單 月 銷 量 分 別 為
8134/26623/32077/19731 台,同比增幅達到了+159%/+71.7%/+113%/+1494%,前六個
月累計銷售分別 55825/146737/163356/78662 台。
另外,驅逐艦 05/海豚/e 系列則分別錄得 7464/10376/3918 台的銷量。
今明兩年是比亞迪的產品大年,預計合計將推出包括改款車在內的不少於 20 款新車,
今年已經上市了驅逐艦 05、海豹、騰勢 D9、22 款唐 EV、22 款漢 EV、DM-i、DM-p 及
秦 PlusDM-i,下半年及明年,比亞迪將繼續發佈騰勢 SUV、軍艦系列、海獅、海鷗,
產品矩陣進一步完善,同時從目前樂觀的預售情況來看,產品單價預計亦將不斷向上
突破。
政策堅定支持下,產能不斷釋放
5 月以來,中國政府宣佈開展新一輪新能源車下鄉活動,6 月召開的國常會明確支持新
能源汽車消費,並考慮延長免征新能源汽車購置稅的優惠政策,共涉及 26 家車企共
69 款車型,覆蓋面相較 2021 年進一步擴大(2021 年涉及 18 個品牌的 52 款車型);

About the author

Zhang Jing

Phillip Securities (HK)

Bachelor Degree in Tongji University of Engineering; Master Degree in East China Normal University of finance. Currently covering the automobile and air sectors. She has years of experience in investment research and is good at combining analysis for the companies with industry prospects.

Latest Reports

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you

IMPORTANT INFORMATION

This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  

 

Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com